Biomerica (BMRA) EBITDA Margin (2010 - 2026)
Biomerica (BMRA) posted EBITDA Margin of 131.51% for Q1 2026, down 15.9% sequentially from 113.47% in Q4 2025, and down 2338.0% YoY from 5.88% in Q1 2025.
Biomerica (BMRA) EBITDA Margin (2010 - 2026) Analysis & Trends
Biomerica has reported EBITDA Margin for 17 years, with the latest figure at 131.51% in Q1 2026.
- Quarterly EBITDA Margin fell 2338.0% year-over-year to 131.51% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 123.74% (down 3394.0% YoY) and the FY2025 annual result came in at 96.72%, up 2086.0% from the prior year.
- EBITDA Margin slipped to 131.51% in Q1 2026 per BMRA's latest filing, from 113.47% in the prior quarter.
- Over five years, EBITDA Margin peaked at 1.4% in Q1 2022 and troughed at 208.81% in Q2 2025.
- A 5-year average of 110.3% and a median of 112.42% in 2022 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin jumped 13027 bps in 2022, then sank 14720 bps in 2023.
- Over 5 years, EBITDA Margin stood at 112.42% in 2022, then advanced by 9 bps to 102.62% in 2023, then jumped by 41 bps to 60.7% in 2024, then plunged by 87 bps to 113.47% in 2025, then dropped by 16 bps to 131.51% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 131.51%, 113.47%, and 81.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 19.15% |
| 10 | Biomerica | 4.79 Mn | 3.45 Mn | -44,000.00 | -131.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -131.51% |
| Nov 30, 2025 | -113.47% |
| Aug 31, 2025 | -81.01% |
| May 31, 2025 | -208.81% |
| Feb 28, 2025 | -108.13% |
| Nov 30, 2024 | -60.70% |
| Aug 31, 2024 | -75.71% |
| May 31, 2024 | -136.92% |
| Feb 29, 2024 | -196.66% |
| Nov 30, 2023 | -102.62% |
| Aug 31, 2023 | -71.92% |
| May 31, 2023 | -165.70% |
| Feb 28, 2023 | -148.60% |
| Nov 30, 2022 | -112.42% |
| Aug 31, 2022 | -126.45% |
| May 31, 2022 | -33.13% |
| Feb 28, 2022 | -1.40% |
| Nov 30, 2021 | -24.31% |
| Aug 31, 2021 | -122.06% |
| May 31, 2021 | -163.40% |